5 things to know before the stock market opens Thursday

Source

1. Stock futures rise after S&P 500, Nasdaq broke 3-day losing streaks

Traders work on the floor of the New York Stock Exchange (NYSE), October 12, 2021.
Brendan McDermid | Reuters

Dow futures gained nearly 300 points Thursday as investors consider a flood of strong bank and health-care-related earnings as well as upcoming data on wholesale inflation and jobless claims. The 10-year Treasury yield dipped to around 1.53%, one day after minutes from the Federal Reserve's latest meeting revealed a "gradual tapering process" of bond purchases could begin by mid-November. U.S. oil prices continued to power higher, jumping to more than $81 per barrel. Bitcoin was up around $58,000. The S&P 500 and Nasdaq on Wednesday broke three-session losing streaks. However, the Dow Jones Industrial Average fell for a fourth straight session.

2. Data on wholesale inflation, jobless claims out before the bell

The government is set to issue two key economics reports at 8:30 a.m. ET: the September producer price index and initial jobless claims. Economists expect first-time filings for unemployment benefits to drop to 318,000 for the week ended Oct. 9. Headline PPI and core PPI, which excludes the food and energy sectors, are expected to remain high, Thursday's wholesale inflation comes after Wednesday's elevated consumer inflation data. With price pressures mounting, the Social Security cost-of-living adjustment next year will be 5.9%, the biggest boost in about 40 years.

3. Banks, health-related companies see shares rise on strong results

The pace of earnings season accelerated Thursday, with slew of banks reporting quarterly results before the bell and their shares moving higher in premarket trading.

Dow stocks UnitedHealth and Walgreens Boots Alliance also reported better-than-expected earnings and revenue. Those stocks jumped in the premarket.

4. FDA vaccine panel gets ready to consider Moderna, J&J boosters

A registered nurse applies a dose of the Moderna COVID-19 vaccine to Sarasota Hospital worker Larry Hammers, 62, at the Sarasota Memorial Hospital in Sarasota, Florida, September 24, 2021.
Shannon Stapleton | Reuters

The FDA's vaccine advisory group meets Thursday to consider a booster for Moderna's two-shot Covid regimen. FDA scientists on Tuesday declined to take a stance it. The agency's panel then meets Friday to consider a booster for Johnson & Johnson's one-dose vaccine and mix-and-match vaccine data. A highly anticipated NIH study, released Wednesday, suggests J&J recipients are better off getting a booster from Pfizer or Moderna. Also on Wednesday, the FDA said data provided by J&J suggests recipients may benefit from an additional dose. A booster of Pfizer's two-shot vaccine was approved for certain groups of people last month.

5. Foreclosures surge as Covid mortgage bailouts expire

fstop123 | E+ | Getty Images

Foreclosures are starting to jump as government and private sector programs designed to help homeowners deal with the economic fallout of the Covid pandemic have begun to expire. Mortgage lenders began the foreclosure process on 25,209 properties in the third quarter, a 32% increase from the second quarter. On a year-over-year basis, it's a 67% rise from the third quarter of 2020, according to Attom, a mortgage data firm. States with the largest number of new foreclosures were California, Texas, Florida, New York and Illinois.

— Follow all the market action like a pro on CNBC Pro. Get the latest on the pandemic with CNBC's coronavirus coverage.